Overview

Impact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
Kuvan® (sapropterin dihydrochloride) for Improving Gastric Accommodation in Women with Diabetic Gastroparesis (KIGA-DG)
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Treatments:
Verapamil